首页> 外文期刊>BMC Biochemistry >The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli : application for identification of potential FRET-dye labeling sites
【24h】

The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli : application for identification of potential FRET-dye labeling sites

机译:结核分枝杆菌拓扑异构酶I的DNA弛豫活性和共价复合物的积累可在大肠杆菌中测定:用于鉴定潜在的FRET染料标记位点的应用

获取原文
           

摘要

Mycobacterium tuberculosis topoisomerase I (MtTOP1) and Escherichia coli topoisomerase I have highly homologous transesterification domains, but the two enzymes have distinctly different C-terminal domains. To investigate the structure-function of MtTOP1 and to target its activity for development of new TB therapy, it is desirable to have a rapid genetic assay for its catalytic activity, and potential bactericidal consequence from accumulation of its covalent complex. We show that plasmid-encoded recombinant MtTOP1 can complement the temperature sensitive topA function of E. coli strain AS17. Moreover, expression of MtTOP1-G116 S enzyme with the TOPRIM mutation that inhibits DNA religation results in SOS induction and loss of viability in E. coli. The absence of cysteine residues in the MtTOP1 enzyme makes it an attractive system for introduction of potentially informative chemical or spectroscopic probes at specific positions via cysteine mutagenesis. Such probes could be useful for development of high throughput screening (HTS) assays. We employed the AS17 complementation system to screen for sites in MtTOP1 that can tolerate cysteine substitution without loss of complementation function. These cysteine substitution mutants were confirmed to have retained the relaxation activity. One such mutant of MtTOP1 was utilized for fluorescence probe incorporation and fluorescence resonance energy transfer measurement with fluorophore-labeled oligonucleotide substrate. The DNA relaxation and cleavage complex accumulation of M. tuberculosis topoisomerase I can be measured with genetic assays in E. coli, facilitating rapid analysis of its activities, and discovery of new TB therapy targeting this essential enzyme.
机译:结核分枝杆菌拓扑异构酶I(MtTOP1)和大肠杆菌拓扑异构酶I具有高度同源的酯交换结构域,但是这两种酶具有截然不同的C端结构域。为了研究MtTOP1的结构功能并以其活性为目标开发新的TB治疗,人们希望对其催化活性以及由于其共价复合物的积累而可能产生的杀菌结果进行快速的基因检测。我们表明质粒编码的重组MtTOP1可以补充大肠杆菌AS17的温度敏感topA功能。此外,具有抑制DNA连接的TOPRIM突变的MtTOP1-G116 S酶的表达导致SOS的诱导和大肠杆菌中活力的丧失。 MtTOP1酶中不存在半胱氨酸残基,使其成为通过半胱氨酸诱变在特定位置引入潜在有用信息的化学或光谱探针的诱人系统。此类探针可能对开发高通量筛选(HTS)分析有用。我们采用了AS17互补系统来筛选MtTOP1中可耐受半胱氨酸替代而不丧失互补功能的位点。证实这些半胱氨酸取代突变体保留了松弛活性。一种这样的MtTOP1突变体用于荧光探针掺入和荧光团标记的寡核苷酸底物的荧光共振能量转移测量。结核分枝杆菌拓扑异构酶I的DNA松弛和切割复合物积累可通过在大肠杆菌中进行基因测定来测量,从而有助于快速分析其活性,并发现针对这种必需酶的新型结核病疗法。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号